PVP-I Use Cases

 Articles
Blog Image
PVP-I Use Cases

July 18, 2025

Can a 0.23% Povidone-Iodine Rinse Shorten COVID-19? A Pilot Study Offers Encouraging Clues

We’ve talked a lot about povidone-iodine (PVP-I) as a potential virus killer, but how does it hold up in the real world—especially in people who already have COVID-19? A recent clinical pilot study from King Saud University Medical City set out to find answers by testing whether low-dose PVP-I nasal rinses and mouthwashes could reduce viral load and shorten the infectious period.

Read Now
Blog Image
PVP-I Use Cases

July 16, 2025

Does Povidone-Iodine Make Periodontal Therapy More Effective? Here's What the Research Says

Chronic periodontitis remains one of the most common oral diseases, and while scaling and root planing (SRP) is the go-to non-surgical treatment, researchers continue to explore ways to boost its effectiveness. One such option? Povidone-iodine (PVP-I).

Read Now
Blog Image
PVP-I Use Cases

July 16, 2025

0.5% Povidone-Iodine: A Safe, Inexpensive Shield Against COVID-19 in ENT Clinics

With the nose and throat being major entry points for SARS-CoV-2, targeted antisepsis is crucial. This study proposes 0.5% povidone-iodine (PVP-I) as a pre-procedure rinse and nasal drop for both patients and healthcare workers.

Read Now
Blog Image
PVP-I Use Cases

July 16, 2025

A 15-Second Mouth Rinse That Destroys COVID-19? New Study Says Yes

With the mouth as a primary entry point for viruses, oral hygiene just became pandemic-critical. A lab-based study reveals povidone-iodine (PVP-I) mouth rinse can inactivate SARS-CoV-2 in seconds.

Read Now
Blog Image
PVP-I Use Cases

July 16, 2025

Can Povidone-Iodine Help Stop COVID-19 Spread in Healthcare Settings?

In the fight to protect frontline workers from COVID-19, one low-cost antiseptic has shown promising potential. Povidone-iodine (PVP-I) nasal sprays and mouthwashes could help reduce transmission when used as a simple pre-procedure rinse.

Read Now
Blog Image
PVP-I Use Cases

July 16, 2025

Understanding the Use of Povidone-Iodine Throat Spray in Infection Prevention

In the fight against sore throats and seasonal viruses, throat disinfectant sprays offer a convenient layer of defense. Among them, povidone-iodine sprays stand out for their strong antiseptic action and ease of use.

Read Now
Blog Image
PVP-I Use Cases

July 16, 2025

Long-Acting Povidone-Iodine Formulations: A Potential Frontline Defense Against SARS-CoV-2

SARS-CoV-2 enters the body primarily through the nasal cavity and, to a lesser extent, the ocular surface. Nasal goblet and ciliated cells, rich in ACE2 and TMPRSS2 receptors, act as early hosts for the virus. These sites also serve as transmission points, particularly when individuals are asymptomatic or mildly symptomatic.

Read Now

PVP-I Use Cases

View More
PVP-I Use Cases

Can a 0.23% Povidone-Iodine Rinse Shorten COVID-19? A Pilot Study Offers Encouraging Clues

We’ve talked a lot about povidone-iodine (PVP-I) as a potential virus killer, but how does it hold up in the real world—especially in people who already have COVID-19? A recent clinical pilot study from King Saud University Medical City set out to find answers by testing whether low-dose PVP-I nasal rinses and mouthwashes could reduce viral load and shorten the infectious period.

Read Now
PVP-I Use Cases

Protecting Healthcare Workers and Patients: The Role of Povidone-Iodine Mouthwash and Nasal Spray in COVID-19 Prevention

During the peak of the COVID-19 pandemic, healthcare workers faced immense exposure risks—often with limited options for protection beyond PPE. But what if a simple mouthwash or nasal spray could offer an additional line of defense? A comprehensive paper explores how povidone-iodine (PVP-I) products might reduce transmission between patients and health professionals alike. Here's how this low-cost, science-backed solution could play a vital role in infection control.

Read Now
PVP-I Use Cases

Can Povidone-Iodine Kill COVID-19 in Just 15 Seconds? New Lab Study Says Yes

While masks and vaccines have dominated COVID-19 headlines, another line of defense has been quietly gaining ground: antiseptic nasal sprays. One in particular—povidone-iodine (PVP-I)—has shown remarkable results in lab studies. A new in vitro (test tube) study published in JAMA Otolaryngology reveals just how fast and effective this simple nasal antiseptic can be against SARS-CoV-2, the virus behind COVID-19.

Read Now
Browse All Blogs!
Categories
PVP-I Use Cases
Prevention
Safety
Immunology
COVID-19 Research
Design and Developed By Flowbuzz. Powered By Webflow